Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
Fabio Catalano(Ospedale Policlinico San Martino), Alberto Puccini(Ospedale Policlinico San Martino), Annalice Gandini(Ospedale Policlinico San Martino), Stefania Sciallero(Ospedale Policlinico San Martino), Silvia Puglisi(Ospedale Policlinico San Martino), Malvina Cremante(Ospedale Policlinico San Martino), Andrea Boutros(The University of Sydney), Valentino Martelli(Ospedale Policlinico San Martino), Roberto Borea(Antwerp University Hospital)
Cited by 42
Related Papers
FGFR a promising druggable target in cancer: Molecular biology and new drugs
|Critical Reviews in Oncology/Hematology|2017|203
The treatment of advanced melanoma: Current approaches and new challenges
|Critical Reviews in Oncology/Hematology|2024|140
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
|Seminars in Cancer Biology|2019|119
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis
|Human Reproduction|2022|105
Current State of Target Treatment in BRAF Mutated Melanoma
|Frontiers in Molecular Biosciences|2020|96